Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Genmab AS (GMAB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Genmab AS's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
31.71 -1.01    -3.09%
27/01 - Closed. Currency in USD ( Disclaimer )
After Hours
31.71
0.00
0.00%
21:44:42 - Real-time Data
  • Volume: 666,464
  • Bid/Ask: 30.00 / 37.00
  • Day's Range: 31.60 - 32.42
Type:  Equity
Market:  United States
ISIN:  US3723032062 
CUSIP:  372303206
Genmab AS 31.71 -1.01 -3.09%

For the nine months ended 30 September 2021, GenmabA/S - ADR revenues decreased 27% to DKR5.86B. Net incomedecreased 45% to DKR2.29B. Revenues reflect a decrease indemand for the Company's products and services due tounfavorable market conditions. Net income also reflectsResearch and development expenses increase of 30% toDKR2.88B (expense), General and administrative expensesincrease of 79% to DKR771M (expense).

TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

GMAB Income Statement

Gross margin TTM -
Operating margin TTM 39.16%
Net Profit margin TTM 36.33%
Return on Investment TTM 13.87%
 Total Revenue  Net Income
Period Ending: Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Total Revenue 2310 1972 1581 2044
Gross Profit
Operating Income 890 787 532 887
Net Income 890 306 1096 581

GMAB Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ 12
LT Debt to Equity MRQ 1.76%
Total Debt to Equity MRQ 2.05%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Total Assets 23985 22483 22210 21143
Total Liabilities 2700 2231 2115 2022
Total Equity 21285 20252 20095 19121

GMAB Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM 1.81
Operating Cash Flow  108.58%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Period Length: 9 Months 6 Months 3 Months 12 Months
Cash From Operating Activities 1987 1540 1185 6433
Cash From Investing Activities -655 966 -579 -2351
Cash From Financing Activities -436 -460 -220 71
Net Change in Cash 1469 2217 632 3708
* In Millions of DKK (except for per share items)
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GMAB Comments

Write your thoughts about Genmab AS
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email